Brachytherapy

 

Contact the SHTG team

Contact Healthcare Improvement Scotland with any SHTG questions:

Project Coordinator
Doreen Pedlar -  0141 225 6998 

Project Administrator
Kay Bagri - 0141 227 3278

Lead Health Services Researcher
Karen Macpherson

Lead for SHTG
Susan Myles

Brachytherapy to treat different types of cancer: an overview of the evidence

Brachytherapy can be used in the treatment of certain cancers. It involves placing a radiation source close to (intracavitary or intraluminal therapy) or into the tumour or treatment site (interstitial therapy). It can be used alone, or in combination with other therapies. High dose rate  brachytherapy uses radionuclides such as iridium-192 at dose rates of 20 cGy per minute or more. Low dose rate brachytherapy can be practised using a variety of sources (eg radium-226, cesium-137 and iodine-125) and is delivered at dose rates of 4–200 cGy per hour.

This report summarises systematic reviews (published since 2005) and evidence based guidelines on the use of brachytherapy to treat different types of cancer. Supplementary searches for primary studies were conducted in order to update the included systematic reviews. Economic evidence (post 2005) has also been summarised. The evidence is presented for each type of cancer separately.

Published Date: 20 December 2011